GB Patent

GB1566609A — Pharmaceutical compositions containing cholestyramine and alginic acid

Assigned to Reckitt Benckiser Healthcare UK Ltd · Expires 1980-05-08 · 46y expired

What this patent protects

Patent listed against maralixibat-chloride.

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: GB1566609A
Jurisdiction: GB
Classification: —
Expires: 1980-05-08
Drug substance claim: No
Drug product claim: No
Assignee: Reckitt Benckiser Healthcare UK Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.